Your browser doesn't support javascript.
loading
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
Weinberg, Olga K; Siddon, Alexa; Madanat, Yazan F; Gagan, Jeffrey; Arber, Daniel A; Dal Cin, Paola; Narayanan, Damodaran; Ouseph, Madhu M; Kurzer, Jason H; Hasserjian, Robert P.
Afiliação
  • Weinberg OK; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Siddon A; Department of Pathology, Yale School of Medicine, New Haven, CT.
  • Madanat YF; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Gagan J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Arber DA; Department of Pathology and Laboratory Medicine, University of Chicago, Chicago, IL.
  • Dal Cin P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Narayanan D; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Ouseph MM; Department of Pathology, Weill Cornell Medical College, New York, NY.
  • Kurzer JH; Department of Pathology, Stanford University Medical Center, Palo Alto, CA; and.
  • Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA.
Blood Adv ; 6(9): 2847-2853, 2022 05 10.
Article em En | MEDLINE | ID: mdl-35073573
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Segunda Neoplasia Primária Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Segunda Neoplasia Primária Idioma: En Ano de publicação: 2022 Tipo de documento: Article